Predicting Pathological Complete Response in Neoadjuvant Dual Blockade With Trastuzumab and Pertuzumab in HER2 Gene Amplified Breast Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yi,Xiao

第一单位： Department of Breast Surgery, The First Hospital of Lanzhou University, Lanzhou, China.

作者： Yi,Xiao ^[1] ; Jiahan,Ding ^[2] ; Dachang,Ma ^[3] ; Sheng,Chen ^[1] ; Xun,Li ^[3] ; Keda,Yu ^[2]

作者单位： Department of Breast Surgery, The First Hospital of Lanzhou University, Lanzhou, China. ^[1] Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. ^[2] Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. ^[3]

关键词 HER2-amplified breast cancer neoadjuvant treatment pertuzumab predictive model trastuzumab

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);基因, erbB-2(Genes, erbB-2);人类(Humans);肿瘤辅助疗法(Neoadjuvant Therapy);回顾性研究(Retrospective Studies)

DOI 10.3389/fimmu.2022.877825

PMID 35663978

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交